Cyrus Harmon
Founder at OLEMA PHARMACEUTICALS, INC.
Net worth: 9 M $ as of 30/04/2024
Cyrus Harmon active positions
Companies | Position | Start | End |
---|---|---|---|
OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 07/08/2006 | - |
Founder | 07/08/2006 | - | |
Chief Executive Officer | 01/03/2007 | 01/09/2020 | |
Chief Tech/Sci/R&D Officer | 01/09/2020 | 01/03/2023 | |
President | 01/03/2007 | 01/09/2020 |
Career history of Cyrus Harmon
Former positions of Cyrus Harmon
Companies | Position | Start | End |
---|---|---|---|
AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2002 |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Chief Executive Officer | 01/01/1996 | 01/01/2000 |
Founder | 01/01/1996 | 01/01/2000 |
Training of Cyrus Harmon
University of California, Berkeley | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Chief Executive Officer | 2 |
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
OLEMA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |
- Stock Market
- Insiders
- Cyrus Harmon
- Experience